These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


179 related items for PubMed ID: 6729779

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of heparin, hirudin, and a synthetic thrombin inhibitor on antithrombin III in thrombin-induced disseminated intravascular coagulation in rats.
    Hauptmann J, Brüggener E, Markwardt F.
    Haemostasis; 1987; 17(6):321-8. PubMed ID: 3428717
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Influence of hirudin on the consumption of antithrombin III in experimental DIC.
    Hauptmann J, Brüggener E.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):83-7. PubMed ID: 2459037
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Normal antithrombin-III activity and concentration in experimental disseminated intravascular coagulation.
    Müller-Berghaus G, Niepoth M, Rabens-Alles B, Rump E, Murano G.
    Scand J Clin Lab Invest Suppl; 1985; 178():107-13. PubMed ID: 3867111
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Heparin-enhanced inhibitors during reversible disseminated intravascular coagulation.
    Marbet GA, Griffith MJ, Roberts HR.
    Scand J Clin Lab Invest Suppl; 1985; 178():95-8. PubMed ID: 3867125
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of a synthetic thrombin inhibitor MCI-9038 on experimental models of disseminated intravascular coagulation in rabbits.
    Hara H, Tamao Y, Kikumoto R, Okamoto S.
    Thromb Haemost; 1987 Apr 07; 57(2):165-70. PubMed ID: 3603410
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of thrombin and endotoxin on the in vivo metabolism of antithrombin III (AT III) in dogs.
    Tanaka H, Kobayashi N, Maekawa T.
    Thromb Res; 1985 Nov 01; 40(3):291-306. PubMed ID: 4082111
    [Abstract] [Full Text] [Related]

  • 17. Pregnancy-associated plasma protein-A (PAPP-A) inhibits thrombin-induced coagulation of plasma.
    Bischof P, Meisser A, Haenggeli L, Reber G, Bouvier C, Béguin F, Herrmann WL, Sizonenko PC.
    Thromb Res; 1983 Oct 01; 32(1):45-55. PubMed ID: 6197764
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A purified antithrombin III--heparin complex as a potent inhibitor of thrombin in porcine endotoxin shock.
    Spannagl M, Hoffmann H, Siebeck M, Weipert J, Schwarz HP, Schramm W.
    Thromb Res; 1991 Jan 01; 61(1):1-10. PubMed ID: 2020936
    [Abstract] [Full Text] [Related]

  • 20. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
    Herren T, Straub PW, Haeberli A.
    Thromb Haemost; 1994 Jan 01; 71(1):49-53. PubMed ID: 8165646
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.